EHR: THIN Database (European Union): Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
'''Sponsor, manager or home institution:''' [[dataOwner::Cegedim Health Data]]. | '''Sponsor, manager or home institution:''' [[dataOwner::Cegedim Health Data]]. | ||
'''Type of information:''' The database includes groups of variables such as patient interaction data, [[availableVariable::diagnosis]] information, prescription and [[availableVariable::medical procedures|treatment data]], medical actions and [[availableVariable::check-up examinations|examinations]], [[availableVariable::health record|patient medical history]], measurement and biological data, social and [[availableVariable::region|demographic information]], [[availableVariable::healthcare costs|reimbursement]] and [[availableVariable::sale of medicines|pharmaceutical data]], allergy and sensitivity records, and consolidated health attributes [https://www.cegedim-health-data.com/solutions/real-world-data-evidences/]. | '''Type of information:''' The database includes groups of variables such as patient interaction data, [[availableVariable::diagnosis]] information, prescription and [[availableVariable::medical procedures|treatment data]], medical actions and [[availableVariable::check-up examinations|examinations]], [[availableVariable::health record|patient medical history]], measurement and biological data, social and [[availableVariable::region|demographic information]], [[availableVariable::healthcare costs|reimbursement]] and [[availableVariable::sale of medicines|pharmaceutical data]], allergy and sensitivity records, and consolidated health attributes [https://www.cegedim-health-data.com/solutions/real-world-data-evidences/ Click here to learn more]. | ||
'''Data level:''' [[dataLevel::patient level]]. | '''Data level:''' [[dataLevel::patient level]]. | ||
| Line 11: | Line 11: | ||
'''Number of Records:''' 69 million. | '''Number of Records:''' 69 million. | ||
'''Cancer Areas of Interest:''' [[hasCancerType::C00-C97: All cancer types]] [https://www.cegedim-health-data.com/solutions/real-world-data-evidences/patient-cohort/]. | '''Cancer Areas of Interest:''' [[hasCancerType::C00-C97: All cancer types]]. [https://www.cegedim-health-data.com/solutions/real-world-data-evidences/patient-cohort/ Click here to learn more]. | ||
'''Data access:''' [[dataAvailability::not publicly available]]. Instructions to request data for restricted content were not found. | '''Data access:''' [[dataAvailability::not publicly available]]. Instructions to request data for restricted content were not found. | ||
'''Contact information:''' | '''Contact information:''' [https://www.cegedim-health-data.com/contact-us/ Click here to access]. | ||
Revision as of 19:41, 29 April 2024
Go back to European Union page
Primary purpose: To provide precise, ethical, and actionable anonymized longitudinal health data for research and medical progress, supporting a range of stakeholders including researchers, healthcare practitioners, and pharmaceutical companies [1].
Sponsor, manager or home institution: Cegedim Health Data.
Type of information: The database includes groups of variables such as patient interaction data, diagnosis information, prescription and treatment data, medical actions and examinations, patient medical history, measurement and biological data, social and demographic information, reimbursement and pharmaceutical data, allergy and sensitivity records, and consolidated health attributes Click here to learn more.
Data level: patient level.
Number of Records: 69 million.
Cancer Areas of Interest: C00-C97: All cancer types. Click here to learn more.
Data access: not publicly available. Instructions to request data for restricted content were not found.
Contact information: Click here to access.
